Title |
Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, March 2014
|
DOI | 10.1186/1750-1172-9-34 |
Pubmed ID | |
Authors |
Dawn Mikelonis, Cheryl L Jorcyk, Ken Tawara, Julia Thom Oxford |
Abstract |
Stüve-Wiedemann syndrome (STWS; OMIM #610559) is a rare bent-bone dysplasia that includes radiologic bone anomalies, respiratory distress, feeding difficulties, and hyperthermic episodes. STWS usually results in infant mortality, yet some STWS patients survive into and, in some cases, beyond adolescence. STWS is caused by a mutation in the leukemia inhibitory factor receptor (LIFR) gene, which is inherited in an autosomally recessive pattern. Most LIFR mutations resulting in STWS are null mutations which cause instability of the mRNA and prevent the formation of LIFR, impairing the signaling pathway. LIFR signaling usually follows the JAK/STAT3 pathway, and is initiated by several interleukin-6-type cytokines. STWS is managed on a symptomatic basis since there is no treatment currently available. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Haiti | 1 | 1% |
Peru | 1 | 1% |
Unknown | 66 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 13 | 19% |
Student > Bachelor | 7 | 10% |
Student > Master | 6 | 9% |
Other | 5 | 7% |
Researcher | 5 | 7% |
Other | 16 | 24% |
Unknown | 16 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 25% |
Agricultural and Biological Sciences | 13 | 19% |
Biochemistry, Genetics and Molecular Biology | 10 | 15% |
Business, Management and Accounting | 2 | 3% |
Computer Science | 2 | 3% |
Other | 4 | 6% |
Unknown | 20 | 29% |